GlassScriptPhysician profile
Amber D Roby
NPI 1104834886
$2,494.29
in general payments reported to CMS, 2019-2025
16 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $65.63 · 2021: $521 · 2022: $346 · 2023: $526 · 2024: $405 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035 · Entertainment: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.28 |
| Entertainment | $166.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $638.75 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $595.95 | 2019-2025 | Tryptyr, Total30, Precision7 |
| Optos, INC. | $166.34 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Harrow Eye, LLC | $165.66 | 2024-2025 | Vevye |
| The Cameron-Ehlen Group, INC. | $162.50 | 2021 | |
| Rxsight INC | $162.27 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Ivantis, INC | $136.52 | 2019 | |
| Glaukos Corporation | $125.38 | 2021 | |
| Allergan, INC. | $123.39 | 2022 | |
| Abb Con-Cise Optical Group LLC | $64.90 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $64.28 | 2022-2023 | Miebo, Lotemax Sm |
| Astellas Pharma US INC | $23.08 | 2024 | Izervay |
| Abbvie INC. | $22.70 | 2023 | Lumigan |
| Eyevance Pharmaceuticals LLC | $17.89 | 2019 | |
| Shire North American Group INC | $12.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Roby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.